Literature DB >> 22015995

Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease.

Avital L Amir1, Renate S Hagedoorn, Simone A P van Luxemburg-Heijs, Erik W A Marijt, Alwine B Kruisselbrink, J H Frederik Falkenburg, Mirjam H M Heemskerk.   

Abstract

After HLA class I-mismatched stem cell transplantation, allo-HLA-directed CD8 T cell responses can be activated without the help of CD4 T cells if memory CD8 T cells cross-reactive against the allo-HLA class I are present or if naïve CD8 T cells are administered during inflammatory conditions. However, in the absence of inflammatory conditions, cooperation between CD4 and CD8 T cells likely is required for an effective primary CD8 T cell response directed against allo-HLA class I. In this study we investigated whether a coordinated response of CD8 and CD4 T cells could be demonstrated in an HLA class I-directed immune response in a patient who developed severe graft-versus-host disease (GVHD) after the administration HLA-A2-mismatched donor lymphocyte infusion in the absence of inflammatory conditions. A previously administered donor lymphocyte infusion from the same donor did not lead to an immune response, excluding the presence of a substantial pool of CD8 T cells cross-reactive against HLA-A2 within the memory T cell compartment of the donor. Analysis of isolated donor CD8 and CD4 T cell clones activated during the GVHD revealed a polyclonal CD8 T cell response directed against the mismatched HLA-A2 and a polyclonal CD4 T cell response recognizing HLA-A2-derived peptides presented in HLA class II. In addition, leukemic blasts present at the time of the emergence of GVHD expressed HLA-A2 and HLA class II and could activate both the CD4 and CD8 alloreactive T cells. Our results demonstrate that the GVHD was mediated by a cooperative CD4 and CD8 response directed against the mismatched HLA-A2 and suggest that leukemic blasts possibly activated this CD8 and CD4 T cell response.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015995     DOI: 10.1016/j.bbmt.2011.10.018

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  11 in total

1.  Complete donor chimerism is a prerequisite for the effect of Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) on acute graft-versus-host disease.

Authors:  Kirsten A Thus; Roel A de Weger; Talitha A de Hoop; Valeria E Boers Trilles; Jürgen Kuball; Eric Spierings
Journal:  Chimerism       Date:  2015-12-15

2.  Mesenchymal stem cells suppress CD8+ T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-β.

Authors:  Mingfen Li; Xuyong Sun; Xiaocong Kuang; Yan Liao; Haibin Li; Dianzhong Luo
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

3.  The role of self-peptides in direct T cell allorecognition.

Authors:  Hossam A Abdelsamed; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

4.  HLA monomers as a tool to monitor indirect allorecognition.

Authors:  Eytan Breman; Paula P van Miert; Dirk M van der Steen; Mirjam H Heemskerk; Ilias I Doxiadis; Dave Roelen; Frans H Claas; Cees van Kooten
Journal:  Transplantation       Date:  2014-06-15       Impact factor: 4.939

5.  Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition.

Authors:  Eytan Breman; Jurjen M Ruben; Kees L Franken; Mirjam H M Heemskerk; Dave L Roelen; Frans H Claas; Cees van Kooten
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

6.  Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT.

Authors:  Mahinbanu Mammadli; Weishan Huang; Rebecca Harris; Hui Xiong; Samuel Weeks; Adriana May; Teresa Gentile; Jessica Henty-Ridilla; Adam T Waickman; Avery August; Alaji Bah; Mobin Karimi
Journal:  iScience       Date:  2021-03-11

7.  Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.

Authors:  Mahinbanu Mammadli; Weishan Huang; Rebecca Harris; Aisha Sultana; Ying Cheng; Wei Tong; Jeffery Pu; Teresa Gentile; Shanti Dsouza; Qi Yang; Alaji Bah; Avery August; Mobin Karimi
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

8.  Assay and Isolation of Single Proliferating CD4+ Lymphocytes Using an Automated Microraft Array Platform.

Authors:  Cody A LaBelle; Raymond J Zhang; Paul M Armistead; Nancy L Allbritton
Journal:  IEEE Trans Biomed Eng       Date:  2019-11-26       Impact factor: 4.538

9.  Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.

Authors:  Ulrike Gerdemann; Usha L Katari; Anastasia Papadopoulou; Jacqueline M Keirnan; John A Craddock; Hao Liu; Caridad A Martinez; Alana Kennedy-Nasser; Kathryn S Leung; Stephen M Gottschalk; Robert A Krance; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop; Ann M Leen
Journal:  Mol Ther       Date:  2013-06-20       Impact factor: 11.454

10.  Deletion of AMPK minimizes graft-versus-host disease through an early impact on effector donor T cells.

Authors:  Darlene A Monlish; Kevin J Beezhold; Pailin Chiaranunt; Katelyn Paz; Nathan J Moore; Andrea K Dobbs; Rebecca A Brown; John A Ozolek; Bruce R Blazar; Craig A Byersdorfer
Journal:  JCI Insight       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.